Suppr超能文献

接受雌激素 - 孕激素治疗患者的纤维蛋白原和凝血因子VII水平

[Fibrinogen and factor VII levels in patients under estrogen-progestin therapy].

作者信息

Tani M, Bossini S, Maffetti G

机构信息

Laboratorio Analisi Chimico-Cliniche e Microbiologia, Ospedale Civile, Gavardo, Brescia.

出版信息

Minerva Ginecol. 1991 Nov;43(11):519-24.

PMID:1784409
Abstract

During a 3 month period the Authors have evaluated the possible modification of some coagulation parameters which can be of relevance for thrombophilic state. Fibrinogen and factor VII were measured and following 3 months of oestro-progestinic treatment in 11 women in good general health and without known controindications to contraceptive treatment. No significant difference in some levels of fibrinogen and factor VII were found. We conclude that in the short term fibrinogen and factor VII are not significantly altered but a longer period of follow up is indicated in order to estimate the risk of cardiovascular accidents.

摘要

在3个月的时间里,作者评估了一些可能与血栓形成倾向相关的凝血参数的变化。对11名身体健康且无已知避孕治疗禁忌证的女性进行了雌激素 - 孕激素治疗3个月后,测量了纤维蛋白原和凝血因子VII。未发现纤维蛋白原和凝血因子VII的某些水平有显著差异。我们得出结论,短期内纤维蛋白原和凝血因子VII没有显著改变,但为了评估心血管意外的风险,需要进行更长时间的随访。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验